glp 1 and pulmonary embolism GLP-1 Therapies May Benefit MPN MDS Patients GLP-1 RA Use Beneficial in

It is therefore clear that currently available GLP-1RAs, mimicking on the peripheral action of GLP-1 (7-36) NH2 , not only ignore the yet unknown physiology of GLP-1 (9-36) NH2 or its metabolites, but they also fail to address the tissue specific physiology of GLP-1 (7-36) NH2 , while pushing to supra-physiological limits the endocrine GLP-1 receptor axis, likely explaining the reported side-effects and only partial success in the treatment of T2D

Healthcare professionals emphasise honest, non-judgemental communication about all substance use, including cannabis, when prescribing Wegovy

Perez-Torres, I., Guarner-Lans, V

This work remains early-stage and confined to animal and in-vitro studies

The next tool helps protect it

Considering again that the myogenic stem cell activator HGF is found in an ECM-bound state 19,20,21,22,26 and undergoes nitration of tyrosine residues (Y198 and Y250) with aging 32,32,62 and muscle disuse (Kuwakdo et al., 2025), the present in vivo experiments provide a robust platform showing the potential for LASSS that could efficiently reduce or delay the nitration-dysfunction of ECM-bound HGF under peroxynitrite-generating conditions